| 摘要 |
The object of the present invention is to quantify glycated albumin, by providing means for providing quantification data, which correlate to the data of the quantification of glycated albumin by the HPLC method, without producing any intercept which might complicate use of the means in clinical medicine in a case where a regression curve is plotted by using the corrective quantification method with use of enzymes. Namely, the invention provides a method of detecting glycated albumin in the serum by using a reagent for assaying fructosamine, which comprises using a reagent for assaying glycated proteins by quantifying glycated proteins in the serum, correcting the value by dividing the thus-obtained value by the total albumin content in the serum and referring to the thus-corrected value as the glycated albumin content in the serum, wherein the method employs, as a glycated albumin standard, glycated albumin obtained from human blood by subjecting an albumin fraction originating in the blood of a healthy human to a treatment for distinguishing glycated albumin from non-glycated albumin. |
